Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-05

Clinical Trial Update: Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

View source ↗

Summary

This clinical trial update describes the FLiPP (Non-alcoholic Fatty Liver Disease Parametric PET) study evaluating PET imaging for NAFLD and NASH, sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Davis | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) | Status: ACTIVE_NOT_RECRUITING